Carlos Rocha-de-Lossada Carmen Alba-Linero Davide Borroni Rahul Rachwani-Anil Francisco Zamorano-Martín Marina Rodríguez-Calvo-de-Mora
Rom J Ophthalmol
2020 Jan-Mar;64(1):62-65.
interferon α-2β conjunctival intraepithelial neoplasia epidermoid carcinoma impression cytology limbal neoplasia ocular squamous surface neoplasia
CC BY
https://pubmed.ncbi.nlm.nih.gov/32292860/
Antineoplastic Agents / therapeutic use Carcinoma in Situ / drug therapy Conjunctival Neoplasms / drug therapy Corneal Diseases / drug therapy Interferon alpha-2 / therapeutic use Neoplasm Recurrence, Local / drug therapy
Antineoplastic Agents / therapeutic use Carcinoma in Situ / drug therapy Conjunctival Neoplasms / drug therapy Corneal Diseases / drug therapy Interferon alpha-2 / therapeutic use Neoplasm Recurrence, Local / drug therapy Case Reports Administration, Ophthalmic Carcinoma in Situ / pathology Conjunctival Neoplasms / pathology Corneal Diseases / pathology Humans Male Middle Aged Neoplasm Recurrence, Local / pathology Ophthalmic Solutions Antineoplastic Agents Interferon alpha-2 Ophthalmic Solutions
PMC7141926
32292860
Relapsed ocular squamous surface neoplasia treated with topical interferon alfa-2b
2020